Sjogren's Syndrome Clinical Trials
A listing of Sjogren's Syndrome medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 144 clinical trials
A randomized, double-blind, placebo controlled, 3-arm multicenter phase 3 study to assess the efficacy and safety of ianalumab in patients with active Sjögren’s syndrome
Participants who complete the 52-week treatment will be entitled to receive ianalumab treatment thereafter via Post Trial Access, in a separate extension study.
- 0 views
- 30 Dec, 2022
- 1 location
Disease Modification in Sjogren's Syndrome Measured by Ultrasound
Disease Modification in Sjogren's Syndrome Measured by Ultrasound
- 1113 views
- 25 Mar, 2021
- 1 location
A Double-Masked , Randomized, Multi-Center Phase1/2 Study to Evaluate the Efficacy and Safety of the Drug in Subjects with Dry Eye Associated with Sjogren's Syndrome.
A Double-Masked , Randomized, Multi-Center Phase1/2 Study to Evaluate the Efficacy and Safety of the Drug in Subjects with Dry Eye Associated with Sjogren's Syndrome.
- 978 views
- 25 Mar, 2021
- 1 location
A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
- 248 views
- 25 Mar, 2021
- 1 location
COVID-19 VACCINE SAFETY AND EFFECTIVENESS
A longitudinal open-label study will include health professionals and patients with immune-mediated inflammatory diseases (IMID) who will receive the ChAdOx1 nCoV-19 vaccine (AZD1222), in a standard 3-dose schedule with an interval of 12 weeks (first-second dose) and 24 weeks (second-thrid dose), in the vaccination campaign against SARS-CoV-2 to assess the …
- 0 views
- 02 Dec, 2021
- 1 location
New Clinical End-points in Patients With Primary Sjögren's Syndrome (NECESSITY)
There are no approved treatments for pSS and the clinical endpoints currently used in clinical trials are inadequate to capture all aspects of the disease that should be evaluated in clinical trials. The newly developed composite endpoint: Sjögren's Tool for Assessing Response to treatment (STAR) will allow a more specific …
- 4 views
- 14 May, 2022
- 1 location
Topical Infliximab for Sterile Corneal Melt
a sterile corneal melt (without an infection) caused by diseases such as rosacea, Sjogren's syndrome, rheumatoid arthritis, Crohn's disease, Stevens Johnson syndrome, as well as toxic epidermal
- 11 views
- 24 Feb, 2022
- 1 location
Stability of Short Implants Versus Standard Blx Implants With Internal Sinus Floor Elevation in Posterior Maxilla: RCT
closed sinus lift (Nkenke E & Stelzle F, 2009; Schropp et al, 2003). The use of short implants is a valid alternative for these procedures (Wallace SS & Froum SJ, 2003) sparing the need of
- 0 views
- 09 Apr, 2023
- 1 location
BI-1808 as a Single Agent and With Pembrolizumab in Treatment of Advanced Malignancies(Keynote-D20)
iRECIST can be applied for efficacy assessment) and subjects with cutaneous T-cell lymphoma (CTCL), specifically Sézary Syndrome (SS) and mycosis fungoides (MF). The study will consist of 2 phases
- 38 views
- 07 Oct, 2022
- 5 locations
Effect of Long Term Clarithromycin for Prevention of Exacerbations in Non-cystic Fibrosis Bronchiectasis in Asian Populations
clarithromycin may reduce the exacerbations in middle-aged and elderly patients with non-CF bronchiectasis. The study is aimed to (A) investigate the etiologies and clinical features of patients with bronchiectasis, (B) compare the effect of clarithromycin 250mg daily on the frequency of exacerbations, quality of life and lung function, stratified according …
- 0 views
- 03 Nov, 2021
- 1 location